1 reply to this topic

[Rogerdodger]

Vax worshipers will hate this study, (Unless they are high)

 

Oral CBD Prevented COVID-19 Infection in Real-World Patients, Study Suggests

According to the study, all of the patients were people who had seizure-related conditions, which CBD is often prescribed to treat. Of this group, 6.2 percent returned positive COVID-19 tests or a diagnosis, compared to 8.9 percent in the control group. Among a smaller subset of patients who were likely taking CBD on the dates of their first COVID-19 test, the effect was even more pronounced:

Only 4.9 percent of people taking CBD became infected with COVID-19, compared to 9 percent in the control group. 

"Our results suggest that CBD and its metabolite 7-OH-CBD can block SARS-CoV-2 infection at early and even later stages of infection,” the study states.

 

As detailed in a paper published Thursday in the peer-reviewed journal Science Advances by a team of 33 researchers at the University of Chicago and University of Louisville, a survey of 1,212 U.S. patients taking prescribed CBD found that people taking 100 milligrams-per-milliliter oral doses of CBD returned positive COVID-19 tests at much lower rates than control groups with similar medical backgrounds who did not take CBD.

 

Edited by Rogerdodger, 21 January 2022 - 10:56 AM.

[Russ]

Early Outpatient Treatment for COVID-19: The Evidence

JANUARY 23, 2022 / BRIANPECKFORD

BY PAUL ELIAS ALEXANDER   JANUARY 22, 2022   29 MINUTE READSHARE | PRINT | EMAILFacebookTwitterRedditLinkedInFlipboardTelegramPrintEmailShare

The evidence accumulated very early on in the pandemic that the use of sequenced multi-drug therapeutics (SMDT) under physician guidance was beneficial and that some medications were safe and effective. We refer to repurposed therapeutics that have been regulatory approved and have been used in some instances for decades for other illnesses. 

We have extensively written and published treatment algorithms and protocols as well as evidence of the benefit of early outpatient (ambulatory) treatment of SARS-CoV-2 virus and the consequent disease COVID-19 (1, 2, 3, 4, 5, 6). With highly targeted and SMDT regimens that include early application of antiviral drugs, combined with corticosteroids and anti-platelet/anti-thrombotic/anti-clotting therapeutics, the risk of hospitalization is significantly reduced by as much as by 85 to 90%, and risk of death is eliminated for high-risk patients and younger individuals presenting with severe symptoms. 

 

 

https://peckford42.w...0#comment-18140